BRIEF-TG Therapeutics says mid-stage data published in the British Journal of Haematology

* TG Therapeutics Inc announces publication of clinical data

from the phase 2 trial of TG-1101 (ublituximab) in combination

with ibrutinib in the british journal of haematology

Read more